Poland, Netherlands, Belgium and Hungary Intraocular Lens Market: By Product Type (Monofocal Lens, Toric Lens, EDoF Lens, Multifocal Lens Others) By Type (Traditional, Premium) By Material (Hydrophobic Acrylic IOL's, Hydrophilic Acrylic IOL's, PMMA IOL's Others) By End User (Hospitals, Ophthalmology Clinics) and Country Forecast 2020-2031

Poland, Netherlands, Belgium, and Hungary Intraocular Lens Market size was valued at US$ 590 million in 2024 and is projected to reach US$ 910 million by 2031, growing at a 6.3% CAGR from 2025–2031. Intraocular lenses (IOLs) have emerged as the norm for cataract and refractive error surgery, especially among elderly patients. Poland, Belgium, Hungary, and the Netherlands have witnessed a progressive year-to-year increase in the demand for IOLs owing to increased access to eye care services and growing interest in the improvement of vision quality. These intraocular lenses are placed in the eye during cataract surgery to replace the eye's natural lens, and patients today expect IOLs that not only provide them with clarity but freedom of vision. As health systems in these nations have a strong bias towards new medical technology, the IOL market is positioning itself in the premium care mode where outcome in vision is the norm, and not the standard.

Local geography mirrors unique patterns in patient demand and healthcare supply. The Netherlands and Belgium, for instance, saw extra day cataract surgery, which has speeded quicker adoption of IOLs. Poland and Hungary are, nonetheless, benefiting from policy-guided investment in the modernization of public eye care facilities. These forces in general are creating a viable market for domestically and internationally based IOL manufacturers. With innovation expanding boundaries, broadening depth-of-focus lenses to toric forms, the business is more about improving quality of life through targeted vision correction solutions.

Facts & Figures

• Netherland and Belgian urban specialty clinics also experience increasing demand for high-end IOLs based on patient out-of-pocket payment willingness for visual freedom after surgery, particularly by working-age active elderly individuals.
• Poland and Hungary experience ongoing improvement in public hospital facilities, which facilitates increasing volume of cataract surgery and access to new IOL technology, particularly monofocal lenses within the context of national health plan coverage.
• Clinical training alliances with Western European eye care centers are boosting surgery volumes and, consequently, surgeon confidence with the insertion of newer IOLs like toric and EDoF lenses in newer Eastern European sites.
• Outcome simulation and electronic devices are more strongly influencing patient choice, especially in private practice, with virtualized environments being used to display simulated post-operative vision quality prior to lens choice.

     Key Developments

• In June 2025, Johnson & Johnson broadened its intraocular lens presence in Europe, the Netherlands, Belgium, and Poland, with the launch of TECNIS Odyssey IOL, a presbyopia-correcting next-generation IOL. The lens delivers a seamless full range of vision from near too far, designed to reduce patients' dependence on glasses and meet growing demand for lifestyle-enhancing premium IOLs in public and private eye care centers.
• In May 2025, UK's Rayner earned industry acclaim with the King's Award for Enterprise, placing focus on the innovative RayOne EMV IOL, which is gaining popularity in Central and Western Europe. The lens utilizes a non-diffractive, patented optic design to extend range of vision, an appealing choice for Hungarian and Belgian ophthalmologists looking for newest generation yet affordable substitutes to multifocal designs.
• In March 2025, Alcon's Clareon® IOL with the AutonoMe™ delivery system remains the standard for surgery in European eye centers, such as those in Hungary and Poland. Its CE-marked status ensures it offers surgeons an automated single-use injector system to achieve greater precision and fewer risks of contamination, issues of concern in high-volume public health hospital systems.
• In Jan 2025, AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) were approved by the FDA for HR-positive, HER2-low or ultralow Poland, Netherlands, Belgium and Hungary Intraocular Lens. The approval was based on Priority Review, supported by data from the DESTINY-Breast06 trial presented at ASCO 2024.

Poland Netherlands Belgium And Hungary Intraocular Lens Market Segmentation

Based on the product type

• Monofocal Lens
• Toric Lens
• EDoF Lens
• Multifocal Lens
• Others

Monofocal intraocular lenses are share leaders in Western and Central Europe because of their cost-economy, clinical reliability, and good acceptability by public health systems. In Poland and Hungary, where reimbursement for healthcare is the final determinant, monofocal lenses are chosen because they can restore excellent distance vision with fewer post-operative complications. Surgeons prefer to employ such lenses during uneventful cataract surgery because of streamlined surgery protocols and outcome predictability. Though premium lenses are fast picking up in metro cities, monofocal IOLs continue to be the standard in most public ophthalmology institutes. The large patient volume and protocol-based surgeries also go to make their employment even in metro as well as semi-metro centers preferable.

Based on the type

• Traditional
• Premium

Intraocular lenses of high quality, particularly in Belgium and the Netherlands, are increasing their market share due to patients becoming increasingly involved in the decision-making process for the operation and agreeing to pay for better visual results. These lenses, e.g., multifocal and toric lenses, provide an individualized solution to presbyopia as well as astigmatism and thus reduces the number of glasses used post-surgery. With enhanced access to private ophthalmology facilities and lifestyle-relevant advantages increasing in popularity, premium IOLs are being increasingly considered a value-added product and not a luxury item. Its utility is most compelling for young cataract cases and refractive lens exchange cases. The technologically advanced surgery facilities of these countries are the root of the movement towards more advanced lens products.

Based on the material

• Hydrophobic Acrylic IOL’s
• Hydrophilic Acrylic IOL’s
• PMMA IOL’s
• Others

Hydrophobic acrylic IOLs are leading the way in all four nations due to their industry-leading biocompatibility, lower inflammatory response, and lower rates of posterior capsule opacification (PCO). Lenses are more widely popular in Belgium and the Netherlands, where precision results matter and surgeons must provide extended clarity with fewer follow-ups. Its foldable nature makes it ideal to use for performing micro-incision surgeries, providing rapid recovery rates and minimizing intraoperative complications. Moreover, hydrophobic acrylic lenses show superior adhesion with the capsular bag, avoiding lens rotation and providing stability to vision. Their reliability in performance and superior clinical record keep them in favor as the gold standard for cataract and refractive lens surgery.

Based on the end user

• Hospital
• Ophthalmology Clinics

The major end consumers of intraocular lenses in Hungary and Poland are still hospitals, where cataract surgery is typically covered by national health insurance schemes and performed through high-volume operating theatre units. Clinically approved low-cost IOLs are still the hospital's preference to ensure effective demand management in a manner that is consistent with patient safety and quality outcomes. These are the only public hospitals that do most of the cataract surgery under standardized treatment protocols. Teaching hospitals and university hospitals in the Netherlands and Belgium are also the targets for innovation, with several of them embracing newer IOL technology and being involved with active clinical trials. Hospital purchasing systems and high procedure volumes in hospitals make them the nodes of important adoption of IOL in the region.